◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

SUPERNUS PHARMACEUTICALS, INC.

CIK: 1356576 SIC: 2834
$718.95M
Revenue
$-38.55M
Net Income
89.63%
Gross Margin
-8.66%
Op. Margin
$164.62M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 14 of 39 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
+ Total Revenue $211.57M $192.10M $165.45M $149.82M $174.16M $175.69M $168.32M $143.64M $164.31M $153.88M $135.56M $153.76M $167.33M $177.35M
Revenue Growth % (YoY) 21.5% 9.3% -1.7% 4.3% 6.0% 14.2% 24.2% -6.6% -1.8% -13.2% nan% nan% nan% nan%
Cost of Revenue $23.01M $18.96M $16.83M $15.76M $26.10M $17.58M $17.92M $16.31M $19.63M $19.60M $21.09M $23.46M $22.95M $25.88M
+ Gross Profit $188.56M $173.14M $148.63M $134.06M $148.06M $158.11M $150.41M $127.33M $144.69M $134.28M $114.47M $130.30M $144.37M $151.47M
Gross Margin % 89.1% 90.1% 89.8% 89.5% 85.0% 90.0% 89.4% 88.6% 88.1% 87.3% 84.4% 84.7% 86.3% 85.4%
Operating Expenses $215.51M $252.33M $153.31M $160.08M $152.75M $134.84M $145.76M $146.80M $165.31M $145.74M $153.15M $148.59M $132.99M $178.88M
Research & Development $27.83M $29.37M $22.11M $26.93M $28.65M $29.04M $26.18M $24.93M $23.35M $22.66M $24.38M $21.21M $17.77M $19.55M
Selling General & Admin $122.39M $179.68M $93.55M $89.94M $79.41M $69.75M $85.90M $86.52M $81.28M $82.70M $86.78M $85.60M $73.97M $112.31M
+ Operating Income $-3.94M $-60.23M $12.14M $-10.26M $21.41M $40.84M $22.57M $-3.15M $-996.00K $8.14M $-17.59M $5.18M $34.33M $-1.52M
Operating Margin % -1.9% -31.4% 7.3% -6.8% 12.3% 23.2% 13.4% -2.2% -0.6% 5.3% -13.0% 3.4% 20.5% -0.9%
Interest Expense - - - - - - - - $-1.09M - $910.00K $1.50M - $1.72M
Other Income/Expense $2.02M $2.28M $4.53M $4.42M $4.98M $4.10M $3.73M $3.40M $-429.00K $1.75M $1.37M $5.35M $-4.67M $2.80M
Income Before Tax $-1.91M $-57.95M $16.67M $-5.83M $26.38M $44.94M $26.30M $243.00K $990.00K $9.89M $-17.13M $9.02M $35.14M $-444.00K
Income Tax Expense $2.19M $-12.84M $-5.83M $6.00M $11.05M $6.45M $6.39M $119.00K $-185.00K $25.86M $-16.30M $-7.93M $9.66M $-2.19M
+ Net Income $-4.11M $-45.12M $22.50M $-11.83M $15.33M $38.50M $19.92M $124.00K $1.18M $-15.98M $-831.00K $16.95M $25.48M $1.75M
Net Margin % -1.9% -23.5% 13.6% -7.9% 8.8% 21.9% 11.8% 0.1% 0.7% -10.4% -0.6% 11.0% 15.2% 1.0%
Basic EPS -0.07 -0.80 0.40 -0.21 0.28 0.70 0.36 0.00 0.02 -0.29 -0.02 0.31 0.47 0.03
Diluted EPS -0.07 -0.80 0.40 -0.21 0.27 0.69 0.36 0.00 0.02 -0.29 -0.02 0.29 0.42 0.03
Basic Shares Outstanding - 56.6M 56.0M 55.9M 123K 55.1M 55.0M 54.8M 38K 54.6M 54.5M 54.4M 147K 53.8M
Diluted Shares Outstanding - 56.6M 56.6M 55.9M 167K 56.0M 55.7M 55.6M -68K 54.6M 54.5M 62.5M 137K 55.0M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Cash & Cash Equivalents $128.45M $151.37M $144.71M $115.85M $69.33M $31.67M $52.09M $63.40M $75.05M $94.98M $24.71M $58.44M $93.12M $111.49M
Short-term Investments - - - - - - - - $179.82M - - - $368.21M $280.30M
Accounts Receivable $187.80M $171.25M $140.83M $145.64M $142.08M $145.41M $152.49M $147.73M $144.16M $141.76M $136.56M $143.57M $165.50M $164.09M
Inventory $112.48M - $44.02M $49.42M $54.29M $63.98M $68.16M $75.08M $77.41M $83.48M $90.56M $91.15M $91.54M $83.17M
Other Current Assets $65.33M $62.08M $31.42M $28.93M $36.09M $27.40M $23.17M $23.77M $16.68M $23.93M $44.77M $16.30M $15.78M $24.85M
Total Current Assets $644.18M $593.89M $738.87M $687.58M $686.07M $640.00M $591.00M $544.32M $493.11M $449.36M $423.54M $883.34M $734.15M $663.89M
Property Plant & Equipment $10.53M $10.63M $11.07M $11.34M $11.54M $11.88M $12.27M $12.97M $13.53M $13.69M $14.19M $14.61M - -
Goodwill $124.88M $119.08M $117.02M $117.02M $117.02M $117.02M $117.02M $117.02M $117.02M $117.02M $117.02M $117.02M $117.02M $117.38M
Intangible Assets $569.46M $623.48M $481.31M $502.13M $521.91M $540.16M $559.64M $579.75M $599.89M $641.15M $662.39M $682.50M $702.46M $722.76M
Long-term Investments - - - - - - - - $16.62M - - - $93.90M $131.94M
Other Non-current Assets $63.80M $62.43M $27.96M $29.22M $31.53M $33.65M $35.89M $38.37M $37.51M $38.82M $38.49M $40.18M $39.81M $41.29M
Total Assets $1.45B $1.42B $1.38B $1.35B $1.37B $1.34B $1.32B $1.30B $1.28B $1.29B $1.29B $1.79B $1.70B $1.69B
Accounts Payable $2.68M - - - $4.59M - - - - - - - - -
Accrued Liabilities $107.80M - - - $76.35M - - - - - - - - -
Other Current Liabilities $38.22M $26.32M $27.70M $4.75M - - $3.62M $9.55M $4.28M $710.00K - $7.49M $16.86M $8.19M
Total Current Liabilities $338.17M $330.63M $286.36M $281.77M $292.40M $291.51M $308.66M $314.55M $290.20M $287.53M $252.59M $731.54M $687.96M $725.99M
Long-term Debt - - - - - - - - - - - - - -
Deferred Tax Liabilities - - - $981.00K $4.96M $7.36M $11.44M $19.50M $24.96M $35.22M $44.30M $49.67M $49.81M $58.16M
Other Non-current Liabilities $22.19M $7.82M $7.76M $7.46M $7.60M $7.35M $7.29M $6.90M $6.42M $8.60M $8.73M $8.61M $8.69M $10.37M
Total Liabilities $390.93M $370.09M $318.50M $316.58M $332.34M $335.55M $358.38M $374.92M $356.16M $372.97M $373.19M $879.66M $816.30M $840.33M
Common Stock $57.00K $57.00K $56.00K $56.00K $56.00K $55.00K $55.00K $55.00K $55.00K $55.00K $55.00K $54.00K $54.00K $54.00K
Retained Earnings $517.88M $521.98M $567.10M $544.60M $556.43M $541.10M $502.60M $482.69M $482.56M $481.39M $497.36M $498.19M $481.25M $455.76M
Total Stockholders Equity $1.06B $1.05B $1.06B $1.03B $1.04B $1.01B $957.45M $929.17M $921.52M $912.19M $919.91M $912.15M $886.20M $852.80M
Total Liabilities & Equity $1.45B $1.42B $1.38B $1.35B $1.37B $1.34B $1.32B $1.30B $1.28B $1.29B $1.29B $1.79B $1.70B $1.69B
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Net Income $-4.11M $-45.12M $22.50M $-11.83M $15.33M $38.50M $20.04M $124.00K $1.18M $-15.98M $16.12M $16.95M $25.48M $35.23M
Depreciation & Amortization $25.02M $66.55M $41.74M $20.38M $18.84M $61.57M $41.47M $20.75M $21.68M $63.18M $41.33M $20.60M $20.85M $64.69M
Stock-based Compensation $9.65M $23.40M $15.57M $8.07M $7.63M $20.12M $12.45M $5.90M $6.45M $20.31M $12.39M $6.31M $4.26M $13.31M
Deferred Income Tax $19.00M $-13.80M $-11.15M $-3.99M $-72.00K $-20.06M $-13.60M $-5.48M $-10.46M $-15.26M $-5.99M $-435.00K $-7.76M $-18.56M
Change in Receivables $16.42M $5.88M $-1.25M $3.56M $-3.33M $1.25M $8.34M $3.58M $2.39M $-21.16M $-26.36M $-21.97M $1.41M $14.96M
Change in Inventory $4.18M $3.32M $-9.62M $-4.73M $-3.19M $-12.62M $-8.02M $-1.99M $-5.03M $-1.08M $5.83M $1.85M $11.55M $6.30M
Operating Cash Flow $19.86M $27.47M $89.13M $30.60M $44.41M $127.55M $74.03M $38.40M $44.96M $66.13M $30.25M $49.13M $27.56M $89.26M
Capital Expenditure $427.00K $911.00K $782.00K $327.00K $213.00K $512.00K $312.00K $248.00K $-36.00K $587.00K $437.00K $278.00K $-10.00K -
Acquisitions - $293.09M - - - - - - - - - - - -
Purchases of Investments - - - - - - - - - - - - - $340.67M
Sales of Investments $39.32M $735.16M $266.61M $156.20M $132.98M $365.89M $217.77M - $35.60M - - - - -
Investing Cash Flow $-51.31M $55.42M $6.71M $37.32M $-12.64M $-177.23M $-100.22M $-51.62M $-65.98M $334.71M $300.08M $239.78M $-48.77M $-167.90M
Stock Issued $8.56M $29.06M $5.32M $2.04M $6.88M $8.03M $4.57M $2.91M $3.08M $3.53M $3.76M $1.81M $2.83M $9.59M
Financing Cash Flow $8.53M $604.00K $-20.46M $-21.40M $5.89M $6.30M $3.23M $1.57M $1.09M $-398.97M $-398.74M $80.17M $2.83M $-13.31M
Net Change in Cash $-22.92M $83.49M $75.38M $46.52M $37.66M $-43.38M $-22.96M $-11.65M $-19.93M $1.86M $-68.41M $369.08M $-18.37M $-91.94M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $192.10M - $507.38M -
Cost of Revenue $18.96M - $51.55M -
Operating Expenses $252.33M - $565.73M -
Research & Development $29.37M - $78.41M -
Selling General & Admin $179.68M - $363.17M -
Operating Income $-60.23M - $-58.35M -
Other Income/Expense $2.28M - $11.23M -
Income Before Tax $-57.95M - $-47.12M -
Income Tax Expense $-12.84M - $-12.67M -
Net Income $-45.12M $19.92M $-34.45M -
Basic EPS -0.80 - -0.61 -
Diluted EPS -0.80 - -0.61 -
Basic Shares Outstanding $56.55M - $56.13M -
Diluted Shares Outstanding $56.55M - $56.13M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $151.37M $69.33M
Accounts Receivable $171.25M $142.08M
Other Current Assets $62.08M $36.09M
Total Current Assets $593.89M $686.07M
Property Plant & Equipment $10.63M $11.54M
Goodwill $119.08M $117.02M
Intangible Assets $623.48M $521.91M
Other Non-current Assets $62.43M $31.53M
Total Assets $1.42B $1.37B
Other Current Liabilities $26.32M -
Total Current Liabilities $330.63M $292.40M
Deferred Tax Liabilities - $4.96M
Other Non-current Liabilities $7.82M $7.60M
Total Liabilities $370.09M $332.34M
Common Stock $57.00K $56.00K
Retained Earnings $521.98M $556.43M
Total Stockholders Equity $1.05B $1.04B
Total Liabilities & Equity $1.42B $1.37B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-45.12M $19.92M $-34.45M -
Depreciation & Amortization - - $66.55M -
Stock-based Compensation - - $23.40M -
Deferred Income Tax - - $-13.80M -
Change in Receivables - - $5.88M -
Change in Inventory - - $3.32M -
Operating Cash Flow - - $27.47M -
Capital Expenditure - - $911.00K -
Acquisitions - - $293.09M -
Sales of Investments - - $735.16M -
Investing Cash Flow - - $55.42M -
Stock Issued - - $29.06M -
Financing Cash Flow - - $604.00K -
Net Change in Cash - - $83.49M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...